|1||Active, not recruiting||
Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations
ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems
ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer
AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas
† Study has passed its completion date and status has not been verified in more than two years.